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Summary 
Coronary angioplasty is complicated by acute occlusion (within 24 hours) and late restenosis (within 6 
months) in 2-5% and 20-40% of the cases, respectively. Vascular endoprostheses (stents) may provide the 
cardiologist with a solution to some of these complications. Several stent-devices are now available for 
experimental nd clinical evaluation. In this study we describe our experience with two metallic stents in 
normal arteries of swine. 
Self-expandable, stainless steel stents (3.5 mm diameter) were implanted in 17 peripheral rteries, eight of 
which were deendothelialized by prior balloon angioplasty. Following implantation, the animals received 
antithrombotic herapy with acenocoumarol and aspirin (8 stents), or aspirin alone (9 stents). After 1 week 
repeat angiography was performed, which showed patency of all stented arteries. Microscopy showed 
complete covering by neointima, 80/xm in thickness. This self-expandable stent (SES) and a balloon- 
expandable stent (BES), constructed oftantalum, were implanted innormal coronary arteries. SES (3.0 and 
3.5 mm) receiving animals were treated with coumadines (10 stents) or received no antithrombotic treatment 
(16 stents) after implantation. BES receiving animals were also not treated (10 stents). Three untreated 
animals with SES died suddenly within 48 hours. Postmortem examination showed partial or complete 
thrombosis of all six stents in these animals, resulting in a patency rate of 62% after 1 week. All animals with 
SES, which were treated with coumadines, and all animals with BES (untreated) had patent stents after one 
week. It is concluded that SES implanted innormal coronary arteries of pigs, which do not receive additional 
antithrombotic reatment, show a 38% occlusion rate within 48 hours, but show 100% patency after t week, 
when the animals are treated with coumadines. BES implanted innormal coronary arteries of pigs, which do 
not receive antithrombotic drugs, are 100% patent after 1 week. 
Introduction 
The application of percutaneous transluminal cor- 
onary angioplasty (PTCA) for the treatment of 
atherosclerotic coronary artery disease has in- 
creased considerably in recent years. The initial 
success rate is high [1, 2], with an incidence of acute 
or subacute occlusion at the site of angioplasty of 
2-5% [3, 4]. Restenosis several months after the 
procedure occurs frequently with an incidence of 
20--40% [5-7]. The effect of pharmacological ther- 
apy on acute complications [8-11] and late resteno- 
sis [12] is still unclear. The implantation ofvascular 
endoprostheses was already attempted in the early 
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days of angioplasty for the treatment of procedure- 
related complications and the prevention of reste- 
nosis [13]. Narrowing of the stented segment 
caused by neointimal hyperplasia limited the use of 
these devices. Changes in design, the use of other 
metal alloys, and miniaturization of the endopros- 
theses has resulted in the availability of several 
types of stents for experimental nd clinical eval- 
uation [14-17]. Early experimental nd clinical ex- 
perience, however, indicates that the thrombogen- 
ic nature of most devices remains a concern [18, 
19]. We therefore studied the short-term angio- 
graphic patency of two different stents in pigs, 
treated with different antithrombotic regimen. 
Materials and methods 
Description of the stents 
Self-expandable stent (SES) 
The SES used (Wallstent ®, Medinvent SA, Lau- 
sanne, Switzerland) isa stainless teel, open-weave 
wire mesh. The wires are 80/xm in thickness. The 
elastic properties of this prosthesis are such that its 
diameter can be substantially reduced by elonga- 
tion. It can thus be constrained on a small-diameter 
delivery-catheter (diameter catheter plus stent is 
approximately 1.6mm), which consists of two 
coaxial catheters. The proximal regions of the two 
coaxial catheters are joined by an invaginated roll- 
ing membrane, which effectively retains the pros- 
thesis. Withdrawal of the outer catheter rolls back 
the membrane progressively, thus releasing the 
stent, which tends to return to its original diameter, 
thereby anchoring itself against he arterial wall. 
The unconstrained diameters of the stents used in 
this study were 3.0 and 3.5 mm, with a length of 15 
to 19 ram. 
Balloon-expandable stent (BES) 
The BES used (Wiktor ®, Medtronic Inc., Minnea- 
polis, USA) is constructed of a single tantalum 
wire, which is coiled in interdigitating loops. This 
prosthesis crimped onto the balloon of a standard 
angioplasty catheter. The features of this prosthe- 
sis design are such that by inflating the balloon the 
diameter of the stent increases without altering its 
length. The maximal diameter of the balloon after 
inflation determines the ultimate diameter of the 
prosthesis after implantation. One inflation at 
8 Atm is sufficient to open the stent and allows the 
safe withdrawal of the deflated balloon. The bal- 
loon-diameters of the mounted angioplasty cathe- 
ters used in this study were 3.0 and 3.5 mm, and the 
lengths of the prostheses 14-16 ram. 
Application of the stents 
Peripheral implantations f elf-expandable stents 
After an overnight fast 6 Yorkshire swine (18- 
25 kg) were sedated with 20rag. kg -1 ketamine 
hydrochloride. Following endotracheal intubation 
the animals were connected to a respirator for arti- 
ficial ventilation with a mixture of oxygen and ni- 
trous oxide (1: 2). Anaesthesia was maintained 
with 1-4 vol% enflurane, while pancuronium bro- 
mide was used as a muscle relaxant. An 8F in- 
troduction sheath was placed via the left carotid 
artery in the descending aorta. After intravenous 
administration of 5,000 IU heparin and 100 mg as- 
pirin, an 8F guiding catheter was advanced to the 
aorto-iliac bifurcation. After baseline angiography 
of both femoral arteries an angioplasty balloon 
catheter (balloon size 3.5 mm) was advanced over a 
long guidewire in the left femoral artery. From the 
angiograms, and using the diameter of the guiding 
catheter as a reference, a segment of the left fem- 
oral artery was chosen with a diameter of 3.0 ram. 
Table 1. Diameters and numbers of self-expandable ('WaU- 
stent') and balloon-expandable ('Wiktor') stents implanted i  
peripheral nd coronary arteries of pigs. RCA = right coronary 
artery; LAD= left anterior descending coronary artery; 
LCX = left circumflex coronary artery. 
stent type stent diameter n artery 
'WaUstent' 3.5 mm 
3.5mm 
'Wallstent' 3.0 mm 
3.5mm 
'Wiktor' 3.0 mm 
3.5 mm 
9 right femoral 
8 left femoral 
13 RCA 3, LAD 6, LCX 4 
13 RCA 5, LAD 4, LCX 4 
6 LAD 4, LCX 2 
4 RCA 2, LCX 2 
165 
F/g. 1. Scanning electron microscopical picture (magnification 1,250 x) of porcine femoral arterial segment 7 days after implantation of
a SES. The wires (arrow) are covered with a continuous layer of spindle shaped endothelial cells. Fissures in the endothelial layer are 
caused by the preparation of the specimen. 
At that point the angioplasty balloon was inflated 
twice for 60 s. at 10 Atm inflation pressure. There- 
after the angioplasty catheter was withdrawn, and 
angiography was repeated. A SES (unconstrained 
diameter 3.5 mm) mounted on the tip of the deliv- 
ery catheter was positioned over the long guidewire 
at the dilated arterial segment. After the stent was 
released repeat angiography was performed. The 
same procedure was followed for placement of a 
stent in the right (contralateral) femoral artery, 
except for the fact that angioplasty was not per- 
formed at this side. The catheters were removed, 
and the animals were allowed to recover from 
anaesthesia. After 6-10 days the animals were 
again anaesthetized and angiography of the stent- 
related arteries was performed. Immediately 
thereafter, the stent-containing arterial segments 
were perfused in vivo with saline (perfusion pres- 
sure 75 mmHg), removed and placed in buffered 
glutaraldehyde until preparation for microscopy. 
Thereafter the animals were sacrificed with an 
overdose of pentobarbitone sodium. 
Table 2. Angiographic patency one week after implantation ofstents in peripheral nd coronary arteries of pigs, which received ifferent 
antithrombotic treatment. ASA = acetylsalicylic acid; F/U = follow up. 
stent ype treatment n F/U (days) patency (%) 
'Wallstent' ASA/coumadines 9 6 100 
(peripheral) ASA 8 8-10 100 
'Wallstent' - 16 7 62.5 
(coronary) coumadines 10 7 100 
'Wiktor' - 10 7 100 
(coronary) 
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Fig. 2. Light microscopy of a porcine femoral rtery 8 days after implantation f a SES (magnification 200 x). The voids (asterisk) 
formerly occupied by the stent wires exert pressure tothe media muscularis (M), and are covered by neointima (N). 
Antithrombotic treatment after femoral 
implantation of self-expandable stents 
Starting the day of the procedure two animals (8 
stents) received aily calciparin 25,000 IU subcuta- 
neously until oral acenocoumarol had prolonged 
the prothrombin time threefold. Aspirin 100 mg. 
24h -1 intravenously was also added. The other four 
animals (9 stents) received only 100 mg of aspirin in 
one daily oral dose. 
Coronary implantations with self-expandable 
stents 
After an overnight fast 13 Yorkshire swine (40- 
46kg) were sedated with 20mg- kg -1 ketamine 
hydrochloride. Following endotracheal intubation, 
mechanical ventilation and anaesthesia s de- 
scribed above, a 9F sheath was placed via the left 
carotid artery in the ascending aorta. After in- 
traarterial administration of 5.000IU heparin, 
baseline coronary angiography was performed us- 
ing an 8F guiding catheter. Using the diameter of 
the guiding catheter as a reference, two coronary 
segments with a diameter of approximately 2.5 
and/or 3.0mm were chosen from the angiograms 
from two of the three major coronary arteries (left 
anterior descending coronary artery: LADCA; left 
circumflex coronary artery: LCXCA; right coro- 
nary artery: RCA). A SES, constrained on the 
delivery catheter, was advanced over a long guide- 
wire and positioned in one of the two selected 
coronary segments. After the stent was released, 
angiography was repeated to confirm its proper 
placement. The second stent was released in the 
other coronary segment. Stents with an uncon- 
strained iameter of 3.0 mm were placed in coro- 
nary segments with a measured diameter of 
2.5 mm, and those with an unconstrained diameter 
of 3.5 mm in 3.0 mm vessels. The number of stents, 
diameters and selected coronary arteries are sum- 
marized in Table 1. 
After 7 days the animals were again anaesthe- 
tized and angiography of the stent-containing coro- 
nary arteries was performed. 
Antithrombotic treatment after coronary 
implantation of self-expandable stents 
Eight animals (16 stents) received no antithrom- 
boric treatment after implantation. During o e
week the other five animals (10 stents) received 
acenocoumarol, in a dose that lowered the Quick- 
test to less than 10% of normal, starting the day 
before the procedure. 
Coronary implantations with balloon-expandable 
stents 
After an overnight fast 5 Yorkshire swine (41- 
48 kg) were anaesthetized as described above. A 9F 
sheath was placed via the left carotid artery in the 
ascending aorta. After intraarterial dministration 
of 5,000 IU of heparin, baseline coronary angiogra- 
phy was performed using an 8F guiding catheter. 
From these angiograms two coronary sites in two of 
the tree major coronary branches (LADCA; 
LCXCA; RCA) were chosen as described for the 
SES. Thereafter, a BES was placed at both sites as 
follows: the catheter with the stent crimped onto its 
balloon was positioned at a desired position, and 
the balloon was inflated for 30 s with an inflation 
pressure of 8Atm. Stents mounted on a 3.0mm 
balloon were placed in vessels with an approximate 
diameter of 2.5mm, and stents mounted on a 
3.5 mm balloon were implanted in vessels with a 
diameter of 3.0 mm. Stent diameters, numbers and 
selected coronary vessels are summarized in Table 
1. 
After 7 days the animals underwent repeat an- 
giography under anaesthesia. Thereafter the tho- 
rax was opened by a midsternal split. The ascend- 
ing aorta was cross clamped and 500 ml of saline, 
followed by 400 ml of a phosphate buffered mixture 
of 1% glutaraldehyde and 4% formaldehyde, was 
infused in the aortic root immediately above the 
coronary ostia at a pressure of 120 mmHg. The 
heart was excised, the coronary arteries dissected 
out, and placed in 4% formaldehyde and 1% glut- 
araldehyde inphosphate buffer (pH 7.3) for at least 
48 hours until preparation for microscopy. 
Antithrombotic treatment after coronary 
implantation of balloon-expandable stents 
Antithrombotic drugs were not administered after 
the implantation of the BES. 
Microscopical examination 
After fixation, the stent-containing arterial seg- 
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Fig. 3. Schematic drawing of a section of a stented porcine artery 
(e.g. as in Fig. 2). The average values of the measurements of 
the layers of 4 porcine femoral arteries 6-10 days after place- 
ment of a SES are included. 
ments were divided lengthwise into two equal parts 
using a pair of fine scissors. From one half of each 
vessel the stent wires were removed. Both halves 
were washed in 0.tM cacodylate buffer (pH7.3), 
postfixed in 1% osmium tetroxide and washed 
overnight in 0.1 M cacodylate. The specimen were 
placed in 1% tannic acid for 60 min, 1% Na2SO 4 for 
10 min and again washed in 0.1 M cacodylate buff- 
er. The half of the vessel containing the stent wires 
underwent dehydration i graded ethanol and crit- 
ical point drying with liquid CO2. This part of each 
vessel was mounted on a specimen table and sput- 
tercoated with gold before examination i  a scan- 
ning electron microscope (ISI-DS-130). The other 
half was dehydrated in graded aceton and embed- 
ded in Epon. After sectioning and staining trans- 
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Fig. 4. Angiogram ofthe right coronary artery of a pig 7 days after implantation f a BES. The fine arrows indicate the stented coronary 
segment, which appears patent without narrowing ofthe lumen. The solid arrow marks a clearly visible stent in the LADCA. 
mission microscopy was performed using a Zeiss 
light microscope and a Philips EM 400 electron 
microscope. 
Results 
Peripheral implantations f elf-expandable stents 
One femoral artery (6%) showed complete occlu- 
sion after balloon-denudation, and could not be 
reopened by the intraarterial dministration of iso- 
sorbide dinitrate. As a result, 9 stents were placed 
in right femoral arteries (without angioplasty) and 
8 stents in left femoral arteries (after angioplasty). 
After 6-10 days all stent-containing arteries were 
angiographically patent, without signs of stenosis 
or intraluminal defects (Table 2). This means that 
all stents were patent, irrespective of earlier endo- 
thelial damage or the addition of coumadines to 
aspirin. Scanning electron microscopy showed that 
all stents were covered by an endothelial lining as 
early as 6 days after implantation (Fig. 1). Trans- 
mission microscopy showed that the stent wires 
were incorporated in the arterial wall and covered 
by a neointima (Fig. 2). Measurement of the arte- 
rial layers showed that the media was considerably 
compressed atthe site of the wires (Fig. 3). Median 
thickness of the neointima on top of or between the 
wires was 80/zm (range 50-125/xm). 
Coronary implantation f self-expandable stents 
Three of the 8 animals (6 stents) which did not 
receive additional anticoagulant treatment, died 
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suddenly within 48 hours after implantation. Post- 
mortem examination showed partial or complete 
thrombotic occlusion within all 6 stents. The other 
5 animals in this group survived, and repeat angio- 
graphy after I week revealed normal patency of all 
10 stented coronary arteries in these animals (Table 
2). All 5 animals (10 stents), which received anti- 
thrombotic prophylaxis with coumadines survived. 
Repeat angiography in this group after 1 week re- 
vealed normal patency of all stented coronary seg- 
ments. 
Coronary implantations of balloon-expandable 
stents 
All 5 animals, which received a total number of 10 
BES, survived for one week. Repeat angiography 
at this time showed normal patency of all stented 
coronary arteries, without signs of intraluminal de- 
fects (Table 2; Fig. 4). 
Scanning electron microscopy revealed that the 
stent wires were completely covered by normal 
appearing endothelium after 1 week (Fig. 5). Fur- 
thermore, the luminal surface of the arteries 
showed corrugation between the stent wires. 
Transmission microscopy f the stented segments 
confirmed the incorporation of the stent in the wall 
of the coronary arteries, and considerable com- 
pression of the arterial media. 
Discussion 
Metallic vascular endoprostheses are currently un- 
der investigation i the coronary arterial tree of 
experimental nimals and man. The most impor- 
tant limitations of its widespread use in clinical 
practice are thrombogenicity and restenosis n the 
stent due to neointimal hyperplasia. The most 
promising clinical indications seem to be implanta- 
tions in stenosed aortocoronary venous bypass 
grafts or when used as a 'bail-out'-device for acute 
occlusion after angioplasty [20-22]. Turbulent 
flow, exposure of the subendothelium and accumu- 
lation of prothrombotic factors require, however, 
that a stent-device is athrombogenic. Stainless steel 
Fig. 5. Scanning electron micrograph (magnification 75 x) of a 
segment ofa left circumflex coronary artery 7days after implan- 
tation of a BES. The stent wire (arrows) iscompletely covered 
with an endothelial lining. 
is not the material of choice for use in such a sit- 
uation. Physicochemical nd biological surface 
modification ofthe stent-wires may provide a solu- 
tion [23, 24], but up till now these attempts have 
not been fruitful. 
Stent implantation i the native coronary circu- 
lation immediately after angioplasty for the pre- 
vention or treatment ofrestenosis seems less prom- 
ising than originally envisaged [15]. Although the 
stent improves the immediate post-dilatation result 
[25-27], restenosis within the stented segment oc- 
curs frequently [20, 28, 29]. The present study e- 
scribes for the first time an attempt to compare two 
stent-devices in the same animal model and in the 
same laboratory. Results uggest that the stainless 
steel self-expandable st nt may be more thrombo- 
genic than the tantalum balloon-expandable st nt. 
As both devices are covered by endothelium within 
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7 days,  the need for addi t ional  ant i thrombot ic  
t reatment  may be of short durat ion.  However  cau- 
t ion is requi red when interpret ing the results of the 
present  study. Apar t  f rom the metal l ic  ompos i t ion 
and the mode of  del ivery to the coronary arter ial  
t ree,  many other  var iables are present  between the 
devices. For  instance the signif icance of  wire thick- 
ness, density of the mesh or loops,  and active or 
passive radial  force after p lacement  are not known.  
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